|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 86.66 USD | +0.99% |
|
+2.53% | +9.67% |
| Capitalization | 69.85B 59.41B 55.07B 51.46B 95.93B 6,418B 102B 629B 250B 3,030B 262B 257B 11,023B | P/E ratio 2025 * |
24.2x | P/E ratio 2026 * | 22.5x |
|---|---|---|---|---|---|
| Enterprise value | 77.02B 65.51B 60.72B 56.74B 106B 7,076B 112B 694B 275B 3,341B 289B 283B 12,154B | EV / Sales 2025 * |
3.8x | EV / Sales 2026 * | 3.66x |
| Free-Float |
54.92% | Yield 2025 * |
2.41% | Yield 2026 * | 2.5% |
Last Transcript: Colgate-Palmolive Company
| 1 day | +0.99% | ||
| 1 week | +2.53% | ||
| Current month | +9.67% | ||
| 1 month | +8.42% | ||
| 3 months | +10.48% | ||
| 6 months | -2.40% | ||
| Current year | +9.67% |
| 1 week | 83.56 |  | 86.83 |
| 1 month | 75.96 | | 86.83 |
| Current year | 75.96 | | 86.83 |
| 1 year | 74.54 | | 100.18 |
| 3 years | 67.62 | | 109.3 |
| 5 years | 67.62 | | 109.3 |
| 10 years | 57.41 | | 109.3 |
| Manager | Title | Age | Since |
|---|---|---|---|
Noel Wallace
CEO | Chief Executive Officer | 61 | 02/04/2019 |
Stanley Sutula
DFI | Director of Finance/CFO | 60 | 09/11/2020 |
Gillian Barclay
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
John Cahill
BRD | Director/Board Member | 68 | 06/10/2005 |
Noel Wallace
CHM | Chairman | 61 | 01/04/2020 |
John Bilbrey
BRD | Director/Board Member | 69 | 11/03/2015 |
| Name | Varia. Jan 1. | Weight | AuM | |
|---|---|---|---|---|
 | +3.66% | 2.54% | 484 M€ | |
| +0.75% | 1.94% | 26 M€ |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +0.99% | +2.53% | -1.42% | +14.78% | 69.85B | |
| +0.86% | +3.89% | -9.63% | +6.45% | 349B | |
| +1.00% | +2.15% | -5.91% | +5.31% | 146B | |
| +0.79% | +2.08% | +3.78% | -7.20% | 67.78B | |
| -1.51% | +2.29% | +46.91% | -57.12% | 42.41B | |
| +0.28% | +3.49% | -14.22% | - | 34.1B | |
| -1.70% | -1.22% | -22.84% | -13.00% | 24.98B | |
| +1.75% | -5.99% | -8.29% | -9.20% | 19.38B | |
| -0.45% | +0.28% | +8.31% | +33.83% | 13.81B | |
| -1.21% | +0.86% | -1.07% | -8.04% | 10.02B | |
| Average | +0.08% | +1.21% | -0.44% | -3.80% | 77.75B | |
| Weighted average by Cap. | +0.63% | +2.62% | -4.10% | +1.39% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 20.28B 17.25B 15.99B 14.94B 27.85B 1,863B 29.52B 183B 72.53B 880B 76.03B 74.48B 3,200B | 21B 17.86B 16.56B 15.47B 28.84B 1,929B 30.57B 189B 75.12B 911B 78.75B 77.14B 3,314B |
| Net income | 2.92B 2.48B 2.3B 2.15B 4.01B 268B 4.25B 26.31B 10.45B 127B 10.95B 10.73B 461B | 3.1B 2.64B 2.45B 2.29B 4.26B 285B 4.52B 27.97B 11.1B 135B 11.64B 11.4B 490B |
| Net Debt | 7.17B 6.1B 5.65B 5.28B 9.84B 659B 10.43B 64.57B 25.64B 311B 26.88B 26.33B 1,131B | 7.09B 6.03B 5.59B 5.22B 9.74B 652B 10.32B 63.89B 25.36B 308B 26.59B 26.05B 1,119B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 23/01/26 | 86.66 $ | +0.99% | 5,345,518 |
| 22/01/26 | 85.81 $ | +1.27% | 9,156,715 |
| 21/01/26 | 84.73 $ | -0.83% | 6,621,198 |
| 20/01/26 | 85.44 $ | +1.09% | 9,850,708 |
| 16/01/26 | 84.52 $ | +0.21% | 6,949,978 |
Delayed Quote Nyse, 24 January 2026 at 08:00 am AEDT
More quotes
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- CL Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition